Blockage of HIV-1 production through inhibition of proviral DNA synthesis by N,O-didecanoyl serinal dimethylacetal

IUBMB Life

Volumn 48, Issue 3, 1999, Pages 311-315

  Takamune, Nobutoki ^a   Misumi, Shogo ^a   Furuishi, Kazuchika ^a   Shoji, Shozo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

AIDS; HIV 1; Inhibitor; Proviral DNA synthesis; Serinal derivative

Indexed keywords

ANTIGEN P24; N,O DIDECANOYLSERINALDIMETHYLACETAL; PHORBOL 13 ACETATE 12 MYRISTATE; SERINE DERIVATIVE; UNCLASSIFIED DRUG; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DNA SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PROVIRUS; T LYMPHOCYTE; VIRUS INHIBITION;

ACETALS; ANTI-HIV AGENTS; CELL LINE; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; PROVIRUSES; SERINE; T-LYMPHOCYTES; VIRUS REPLICATION;

DNA VIRUSES; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0032728199     PISSN: 15216543     EISSN: None     Source Type: Journal    
DOI: 10.1080/152165499307026     Document Type: Article

References (18)

1. Carpenter, C. C. J., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schooley, R. T., Thompson, M. A., Vella, S., Yeni. P. G., and Volberding, P. A. (1997) Antiretroviral therapy for HIV infection in 1997. JAMA 277, 1962-1969.
2. Günthard, H. F., Wong, J. K., Ignacio, C. C., Guatelli, J. C., Riggs, N. L., Havlir, D. V., and Richman, D. D. (1998) Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. J. Virol. 72, 2422-2428.
3. Harouse, J. M., Bhat, S., Spitalnik, S. L., Laughlin, M., Stefano, K., Silberberg, D. H., and Gonzalez-Scarano, F. (1991) Inhibition of entry of HFV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 253, 320-323.
4. Harouse, J. M., Collman, R. G., and Gonzalez-Scarano, F. (1995) Human immunodeficiency virus type 1 infection of SK-N-MC cells: Domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfogalactosyl ceramide-positive cell line. J. Virol 69, 7383-7390.
5. Yahi, N., Baghdiguian, S., Moreau, H., and Fantini, J. (1992) Galactosyl ceramide (or a closely related molecule) is the receptor for human immunodeficiency virus type 1 on human colon epithelial HT29 cells. J. Virol. 66, 4848-4854.
6. Fantini, J., Cook, D. G., Nathanson, N., Spitalnik, S. L., and Gonzalez-Scarano, F. (1993) Infection of colonie epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc. Natl. Acad. Sci. U.S.A. 90, 2700-2704.
7. Dalgleish, A. G., Beverley, P. C. L., Clapham, P. R., Crawford, D. H., Greaves, M. F., and Weiss, R. A. (1984) The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-767.
8. Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T., Gluckman, J. C., and Montagnier, L. (1984) T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312, 767-768.
9. Alkhatib, G., Combadiere, C., Broder, C. C., Feng, Y., Kennedy, P. E., Murphy, P. M., and Berger, E. A. (1996) CC CKR5: A RANTES, MIP-1α, MIP-1β receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958.
10. Deng, H., Liu, R., Ellmeier, W., Choe, S., Unutmaz, D., Burkhart, M., Di Marzio, P., Marmon, S., Sutton, R. E., Hill, C. M., Davis, C. B., Peiper, S. C., Schall, T. J., Littman, D. R., and Landau, N. R. (1996) Identification of a major co-receptor for primary isolates of HIV-1. Nature 381, 661-666.
11. + cells is mediated by the chemokine receptor CC-CKR-5. Nature 381, 667-673.
12. Feng, Y., Broder, C. C., Kennedy, P. E., and Berger, E. A. (1996) HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 272, 872-877.
13. Fantini, J., Hammache, D., Delézay, O., Yahi, N., André-Barrés, C., Rico-Lattes, I., and Lattes, A. (1997) Synthetic soluble analogs of galactosylceramide (GalCer) bind to the V3 domain of HIV-1 gp120 and inhibit HIV-1-induced fusion and entry. J. Biol. Chem. 272, 7245-7252.
14. Rivas, C. I., Golde, D. W., Vera, J. C, and Kolesnick, R. N. (1994) Involvement of the sphingomyelin pathway in autocrine tumor necrosis factor signaling for human immunodeficiency virus production in chronically infected HL-60 cells. Blood 83, 2191-2197.
15. Papp, B., Zhang, D., Groopman, J. E., and Byrn, R. A. (1994) Stimulation of human immunodeficiency virus type 1 expression by ceramide. AIDS Res. Hum. Retroviruses 10, 775-780.
16. Harada, S., Koyanagi, Y., and Yamamoto, N. (1985) Infection of human T-lymphotropic virus type-I (HTLV-I)-bearing MT-4 cells with HTLV-III (AIDS virus): chronological studies of early events. Virology 146, 272-281.
17. Walker, B. D., Kowalski, M., Goh, W. C., Kozarsky, K., Krieger, M., Rosen, C., Rohrschneider, L., Haseltine, W. A., and Sodroski, J. (1987) Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine. Proc. Natl. Acad Sci. U.S.A. 84, 8120-8124.
18. Mizrachi, Y., Lev, M., Harish, Z., Sundaram, S. K., and Rubinstein, A. (1996) L-cycloserine, an inhibitor of sphingolipid biosynthesis, inhibits HIV-1 cytopathic effects, replication, and infectivity. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 11, 137-141.